Search hospitals > Connecticut > Bridgeport
Bridgeport Hospital
Claim this profileBridgeport, Connecticut 06610
Global Leader in Breast Cancer
Global Leader in Cardiovascular Disease
Conducts research for Cancer
Conducts research for Myocardial Infarction or Heart Attack
Conducts research for Heart Attack
92 reported clinical trials
6 medical researchers
Summary
Bridgeport Hospital is a medical facility located in Bridgeport, Connecticut. This center is recognized for care of Breast Cancer, Cardiovascular Disease, Cancer, Myocardial Infarction or Heart Attack, Heart Attack and other specialties. Bridgeport Hospital is involved with conducting 92 clinical trials across 137 conditions. There are 6 research doctors associated with this hospital, such as Edward Tuohy, MD, Alisa Savetamal, MD, Caroline Loeser, MD, and Robert Fishman, MD.Area of expertise
1Breast Cancer
Global LeaderPR positive
ER positive
HER2 negative
2Cardiovascular Disease
Global LeaderTop PIs
Edward Tuohy, MDBridgeport Hospital1 year of reported clinical research
Studies High Blood Pressure
Studies Cardiovascular Disease
2 reported clinical trials
2 drugs studied
Alisa Savetamal, MDBridgeport Hospital3 years of reported clinical research
Studies Wound Healing
Studies Burns
2 reported clinical trials
3 drugs studied
Caroline Loeser, MDBridgeport Hospital2 years of reported clinical research
Studies Bowel Prep
Studies Nonalcoholic Steatohepatitis
2 reported clinical trials
10 drugs studied
Robert Fishman, MDAllegheny General Neurology Department/Neuro-Oncology5 years of reported clinical research
Studies Peripheral Neuropathy
Studies Glioblastoma
2 reported clinical trials
3 drugs studied
Clinical Trials running at Bridgeport Hospital
Cardiovascular Disease
Inflammation
Chronic Kidney Disease
Bowel Prep
Atherosclerosis
Elevated Lipoprotein
Atrial Fibrillation
Heart Failure
Cardiovascular Risk
Chronic Disease
Lepodisiran
for Cardiovascular Disease
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke. The study drug will be administered subcutaneously (SC) (under the skin).
Recruiting1 award Phase 3
CagriSema
for Cardiovascular Disease
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardiovascular disease. Participants will either get CagriSema or a dummy medicine (also called "placebo") which has no effect on the body. Which treatment participants will get will be decided by chance. Participant's chance of getting CagriSema or placebo is the same. Participants will inject the study medicine once a week. The study medicine will be injected briefly with a thin needle, typically in the stomach, thighs or upper arms. The study will last for up to 4.5 years.
Recruiting1 award Phase 316 criteria
Ziltivekimab
for Cardiovascular Disease
This study is evaluating whether ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.
Recruiting1 award Phase 32 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Bridgeport Hospital?
Bridgeport Hospital is a medical facility located in Bridgeport, Connecticut. This center is recognized for care of Breast Cancer, Cardiovascular Disease, Cancer, Myocardial Infarction or Heart Attack, Heart Attack and other specialties. Bridgeport Hospital is involved with conducting 92 clinical trials across 137 conditions. There are 6 research doctors associated with this hospital, such as Edward Tuohy, MD, Alisa Savetamal, MD, Caroline Loeser, MD, and Robert Fishman, MD.